A carregar...

Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer

As recruitment for oncology clinical trials has become more difficult, there appears to have been an increase in the number of studies that allow patients in the control arm to “crossover” and receive the experimental therapy after disease progression. Although some researchers worry that allowing s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fojo, Tito, Amiri-Kordestani, Laleh, Bates, Susan E.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3247787/
https://ncbi.nlm.nih.gov/pubmed/22045362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr386
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!